Ingrid Delval

Ingrid Delval is the Chief of Staff to the CEO at AQEMIA, a leading company in generative-AI-driven drug discovery.12 She joined AQEMIA in this role in 2023, expressing enthusiasm about being part of the project.3

Professional Background

Ingrid Delval has a diverse background that includes experience in:

• Finance
• Startups
• Project management
• Sales

She received her education at emlyon business school, which is known for its prestigious programs.2

Current Role at AQEMIA

As Chief of Staff to the CEO at AQEMIA, Ingrid Delval is involved in the company's significant developments:

• She has been part of AQEMIA's growth, including the recent boost in Series A funding to €60 million, which she described as an "incredible milestone".4
• Ingrid is likely working closely with the CEO, Maximilien Levesque, Ph.D., in supporting the company's mission to design innovative drug candidates for critical diseases.15

Professional Network

Ingrid Delval maintains an active professional presence:

• She has over 500 connections on LinkedIn.2
• Her LinkedIn profile username is indeed "ingrid-delval" as mentioned in the query.

Ingrid Delval appears to be an integral part of AQEMIA's team, supporting the company's efforts in using artificial intelligence and deep physics to accelerate drug discovery, particularly in areas such as immuno-oncology.1